Treatment of Urinary Tract Infections Based on Previous Antibiotic Sensitivity

Importance of Culture-Directed Therapy

Clinicians should obtain urinalysis, urine culture, and sensitivity with each symptomatic UTI episode prior to initiating treatment in patients with recurrent UTIs 1
Empirical therapy should be started based on suspected causative organisms' antibiotic sensitivities, then replaced by therapy adjusted for the specific organism(s) identified in the urine culture 2
Microbial confirmation at the time of acute-onset urinary tract-associated symptoms is an essential element in establishing a diagnosis and guiding treatment 1

Nitrofurantoin 100 mg twice daily for 5 days is recommended as a first-line option based on sensitivity results 3
Fosfomycin trometamol (3 g single dose) is another first-line option, though it may have slightly inferior efficacy compared to standard short-course regimens 3

Treat UTI episodes with as short a duration of antibiotics as reasonable, generally no longer than 7 days 1
The standard duration for nitrofurantoin treatment is 5 days, which balances efficacy with minimizing adverse effects 3

In a cohort study of E. coli UTIs, there was high likelihood of persistent resistance to ampicillin (84.9%), amoxicillin-clavulanate (54.5%), ciprofloxacin (83.8%) and TMP (78.3%), while resistance to nitrofurantoin was only 20.2% at 3 months 4
Fluoroquinolones should not be used as first-line therapy for uncomplicated UTIs due to FDA warnings about disabling and serious adverse effects resulting in an unfavorable risk-benefit ratio 4

Patient-initiated treatment (self-start treatment) may be offered to select recurrent UTI patients with acute episodes while awaiting urine cultures 1
Surveillance urine testing should be omitted in asymptomatic patients with recurrent UTIs 1
Asymptomatic bacteriuria should not be treated, as this can increase the risk of antimicrobial resistance 5, 2

Antibiotic stewardship in patients with recurrent UTIs starts with treating all acute UTIs according to clinical practice guidelines using short-duration therapy 4
Longer courses or greater potency antibiotics are not needed in patients with recurrent UTIs and may be associated with more recurrences due to loss of protective periurethral and vaginal microbiota 4
Broad-spectrum antibiotic therapy should be narrowed based on culture sensitivities as soon as possible to avoid selecting resistant pathogens 6